248 related articles for article (PubMed ID: 7529805)
1. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.
Racke MK; Scott DE; Quigley L; Gray GS; Abe R; June CH; Perrin PJ
J Clin Invest; 1995 Nov; 96(5):2195-203. PubMed ID: 7593605
[TBL] [Abstract][Full Text] [Related]
3. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
Quattrocchi E; Dallman MJ; Feldmann M
Arthritis Rheum; 2000 Aug; 43(8):1688-97. PubMed ID: 10943858
[TBL] [Abstract][Full Text] [Related]
5. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.
Issazadeh S; Navikas V; Schaub M; Sayegh M; Khoury S
J Immunol; 1998 Aug; 161(3):1104-12. PubMed ID: 9686568
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
8. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
9. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
Teh HS; Teh SJ
Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
[TBL] [Abstract][Full Text] [Related]
10. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
Elloso MM; Scott P
J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
[TBL] [Abstract][Full Text] [Related]
11. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
12. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.
Guerder S; Carding SR; Flavell RA
J Immunol; 1995 Dec; 155(11):5167-74. PubMed ID: 7594526
[TBL] [Abstract][Full Text] [Related]
13. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
Nikcevich KM; Gordon KB; Tan L; Hurst SD; Kroepfl JF; Gardinier M; Barrett TA; Miller SD
J Immunol; 1997 Jan; 158(2):614-21. PubMed ID: 8992975
[TBL] [Abstract][Full Text] [Related]
15. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2.
Webb LM; Walmsley MJ; Feldmann M
Eur J Immunol; 1996 Oct; 26(10):2320-8. PubMed ID: 8898940
[TBL] [Abstract][Full Text] [Related]
16. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by CTLA4Ig of experimental allergic encephalomyelitis.
Arima T; Rehman A; Hickey WF; Flye MW
J Immunol; 1996 Jun; 156(12):4916-24. PubMed ID: 8648142
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
Perrin PJ; Maldonado JH; Davis TA; June CH; Racke MK
J Immunol; 1996 Aug; 157(4):1333-6. PubMed ID: 8759711
[TBL] [Abstract][Full Text] [Related]
19. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
[TBL] [Abstract][Full Text] [Related]
20. Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation.
Beissert S; Bluestone JA; Mindt I; Voskort M; Metze D; Mehling A; Luger TA; Schwarz T; Grabbe S
J Immunol; 1999 Dec; 163(12):6725-31. PubMed ID: 10586070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
